InsidersTradesSigma
Declaraciones totales
Empresas
▲ Compras (0 oper.)
▼ Ventas (4 oper.)
Historial del iniciado
Director GeneralCompras declaradas
0
Ventas declaradas
4
Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Explore the complete record of transactions filed by Gibson Christopher, Presidente y Director General. Insider active across 2 companies, notably Recursion Pharmaceuticals, INC.. Aggregated, 110 reports have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €1.1m. Activity tracked since 21 November 2021. The latest transaction was filed on 22 May 2026 (C). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Gibson Christopher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones110 en total
40.000 títulos0Class A Common StockSEC:0001856369-26-000019:0
40.000 títulos@ 3,08 US$0.0075% mcap2.3% de su flujoClass A Common StockSEC:0001856369-26-000019:1
40.000 títulos0Class A Common StockSEC:0001856369-26-000013:0
40.000 títulos@ 3,61 US$0.0069% mcap2.6% de su flujoClass A Common StockSEC:0001856369-26-000013:1
57.473 títulos0Common StockSEC:0001856369-26-000010:0
40.000 títulos0Class A Common StockSEC:0001856369-26-000008:0
40.000 títulos@ 3,10 US$2.2% de su flujoClass A Common StockSEC:0001856369-26-000008:1
40.000 títulos0Class A Common StockSEC:0001601830-26-000052:0
20.000 títulos0Class A Common StockSEC:0001601830-26-000049:0
53.913 títulos0Common StockSEC:0001299130-26-000050:0
27.265 títulos@ 3,49 US$1.0% de su flujoClass A Common StockSEC:0001601830-26-000021:0
40.000 títulos0Class A Common StockSEC:0001601830-26-000008:0
40.000 títulos0Class A Common StockSEC:0001856369-26-000005:0
60.000 títulos0Class A Common StockSEC:0001856369-26-000003:0
40.000 títulos0Class A Common StockSEC:0001856369-25-000018:0
60.000 títulos0Class A Common StockSEC:0001856369-25-000016:0
40.390 títulos@ 4,14 US$1.8% de su flujoClass A Common StockSEC:0001856369-25-000014:0
60.000 títulos0Class A Common StockSEC:0001856369-25-000012:0
100.000 títulos0Class A Common StockSEC:0001856369-25-000010:0
120.000 títulos0Class A Common StockSEC:0001856369-25-000007:0
100.000 títulos0Class A Common StockSEC:0001856369-25-000005:0
120.000 títulos0Class A Common StockSEC:0001601830-25-000145:0
100.000 títulos0Class A Common StockSEC:0001601830-25-000136:0
40.390 títulos@ 5,64 US$2.4% de su flujoClass A Common StockSEC:0001601830-25-000132:0
423.666 títulos0Class A Common StockSEC:0001601830-25-000130:0
25 de 110 declaraciones
About Gibson Christopher
Gibson Christopher is Président-Directeur Général and a director of Recursion Pharmaceuticals, INC. and Pacific Biosciences of California, INC., both listed on XNAS. He has 110 filings in total, and across the 110 sampled filings between 2021-12-09 and 2026-05-27, the reported amounts show EUR 0 of buys and EUR 1114641 of sells, with filings of nature C.
